在心肌梗塞后不同时间窗口中预测左心室血栓解脱的因素
Zhen Lu1,2, Bingxue Song1,3, Xin Liu1,3
1Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
BMC cardiovascular disorders
|May 29, 2024
概括
在心肌梗塞后检测左心室血栓 (LVT) 是具有挑战性的. 较高的CRP水平阻碍了急性阶段的LVT解决,而抗凝剂有助于慢性LVT解决.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 医学研究 医学研究
背景情况:
- 左心室血栓 (LVT) 是心肌梗塞后的一个重大并发症.
- 由于其往往无症状的性质,早期检测LVT是很困难的.
- 了解LVT的特定阶段临床相关物对于管理至关重要.
研究的目的:
- 调查与LVT解决相关的临床因素的差异.
- 为了比较急性/亚急性和慢性阶段的LVT相关性,而不是心肌梗塞后的慢性阶段.
主要方法:
- 分析了153名心肌梗塞后LVT患者的队列.
- 患者被分为急性/亚急性 (<30天) 和慢性 (≥30天) 阶段.
- 后勤回归模型评估了结血栓在90天内解脱的相关性.
主要成果:
- 在急性/次急性阶段,较高的C-反应蛋白 (CRP) 水平与较低的LVT解析概率有关 (OR:0.95).
- 在慢性阶段,抗凝剂治疗显著增加了LVT解决的几率 (OR:5.717).
结论:
- 较高的CRP水平与急性心肌梗塞的LVT分辨率降低有关.
- 抗凝药治疗对于治疗慢性心肌梗塞的慢性阶段的LVT仍然很重要.
更多相关视频
06:29Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
10.3K
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.5K
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
137
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
137
Clot Retraction and Fibrinolysis
5.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.5K
